Gilead Gives Royalty-Free Remdesivir Licenses to Five Drugmakers
May 12, 2020
Valerie Bauman
Bloomberg Law
Axinn partner Chad Landmon was quoted in the Bloomberg Law article, "Gilead Gives Royalty-Free Remdesivir Licenses to Five Drugmakers."
Click here to access the article.